NCT06529107

Brief Summary

In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol. It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2024

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

July 20, 2024

Last Update Submit

July 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of urinary complications

    the occurrence of urologic complications within 2 months after discharge of the patients from the hospital for follow-up, which in this study included urinary tract infections, urethral injuries, bladder stones, hydronephrosis

    Within 2 months of discharge

Secondary Outcomes (5)

  • Intermittent Catheterization Compliance Scale

    Pre-intervention, immediately post-intervention, and 1 month post-discharge

  • 12-Item Short Form Survey

    Pre-intervention, immediately post-intervention, and 1 month post-discharge

  • Self-Rating Anxiety Scale

    Pre-intervention, immediately post-intervention, and 1 month post-discharge

  • Intermittent Catheterization Confidence Scale

    Pre-intervention, immediately post-intervention, and 1 month post-discharge

  • Utilization of health services

    Within 2 months of discharge

Study Arms (2)

A best evidence-based protocol for intermittent catheterization

EXPERIMENTAL
Behavioral: intermittent catheterization protocol based on the best evidence

Routine intermittent catheterization care

NO INTERVENTION

Interventions

A best evidence-based protocol for intermittent catheterization after radical cervical cancer surgery

A best evidence-based protocol for intermittent catheterization

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≧ 18 years old
  • Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
  • Patients or their family members can operate a smartphone
  • No cognitive or psychiatric disorders, and can communicate effectively

You may not qualify if:

  • People with serious heart, brain, lung and other important organ diseases
  • People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
  • People with previous serious renal diseases, bladder and urethra surgery
  • People with urinary tract infections
  • People who did not complete all interventions or data collection
  • People who voluntarily withdrew from the study or died during the study period;
  • Refuse to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Second University Hospital, Sichuan University

Chengdu, Sichuan, China

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
deputy head nurse

Study Record Dates

First Submitted

July 20, 2024

First Posted

July 31, 2024

Study Start

January 1, 2024

Primary Completion

December 10, 2024

Study Completion

December 31, 2024

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations